NCT05718401 The Diagnostic Pattern and Prognosis of Multiple Myeloma Patients With Myocardial Amyloidosis Were Evaluated by NMR Based Metabolomics Status UNKNOWN Phase N/A
NCT05714839 A Study to Investigate the Safety and Efficacy of Belantamab for the Treatment of Multiple Myeloma When Used as Monotherapy and in Combination Treatments Status RECRUITING Phase PHASE1/PHASE2
NCT05712967 Role of the Host Microbiota and Il-17 in Favoring Multiple Myeloma Progression Status COMPLETED Phase N/A
NCT05712083 A Study of BCMA CAR-T Cell Therapy for Newly Diagnosed Multiple Myeloma Status UNKNOWN Phase PHASE2
NCT05706766 Prehabilitation Exercise Training in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation Status RECRUITING Phase NA
NCT05700747 Health Through Activity: A Pilot Study of a Rehabilitation Intervention for People Living With Multiple Myeloma Status COMPLETED Phase NA
NCT05698888 Study of VP301 in Patients With Multiple Myeloma, Lymphoma, or Solid Tumors Status TERMINATED Phase PHASE1
NCT05698303 A Study of Fully Human BCMA Chimeric Antigen Receptor Autologous T Cell Injection (CT103A) in the Treatment of Patients With Relapsed/Refractory Multiple Myeloma Status NOT_YET_RECRUITING Phase PHASE1
NCT05697913 Efficacy of Response-adapted Treatment in Patients With Multiple Myeloma Candidates for Bone Marrow Transplantation Status ACTIVE_NOT_RECRUITING Phase NA
NCT05693012 Assessment of Early Detection and Prognosis Based on cfDNA Methylation in Multiple Myeloma Status UNKNOWN Phase N/A
NCT05690984 Elimination of Minimal Residual Disease After Transplant Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05686447 Screening and Therapeutic Monitoring of Multiple Myeloma by MALDI-TOF MS Analysis Status RECRUITING Phase N/A
NCT05679258 A Study to Compare the PK , Safety, Tolerability, and Immunogenicity of HLX15 With Daratumumab in Male Subjects Status COMPLETED Phase PHASE1
NCT05675449 A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05675319 Allogeneic Stem Cell Transplantation vs. Conventional Therapy as Salvage Therapy for Relapsed / Progressive Patients With Multiple Myeloma After First-line Therapy Status TERMINATED Phase PHASE3
NCT05673083 Impact of a Health Technology Intervention on Patient Activation in Multiple Myeloma Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05655546 ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals Status TERMINATED Phase NA